<p>The present invention relates to a mononucleoside phosphonate compound in which the nature of the linkage between the ribosyl or carbocyclic residue and the phosphorous atom of a mononucleotide is modified to include alkylene groups, which improve the stability of the compound. These mononucleoside phosphonate compounds optionally have a degradation-resistant substituent attached on the terminal phosphate. By modification of the linkage and the attachment of the degradation-resistant substituent, the stability of the mononucleoside phosphonate compound significantly improves. The mononucleoside phosphonate compounds of the present invention are useful in preventing and treating diseases or disorders associated with platelet aggregation.</p>
申请公布号
WO2007140333(A2)
申请公布日期
2007.12.06
申请号
WO2007US69795
申请日期
2007.05.25
申请人
SHAVER, SAMMY, R.;INSPIRE PHARMACEUTICALS, INC.;DOUGLASS, JAMES, G., III;WATSON, PAUL, S.
发明人
SHAVER, SAMMY, R.;DOUGLASS, JAMES, G., III;WATSON, PAUL, S.